Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy
Clinical trial NCT02216617 · COMPLETED
Trial details
- NCT number
- NCT02216617
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-06
- Primary completion
- 2015-07-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.